The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
The global 3D protein structure analysis market is rapidly expanding due to growing demand in drug development, personalized medicine, and biotech research. Key opportunities include advancements in ...